| I. LIFE SCIENCES INVESTMENT ADVISORY COMMITTEE (IAC) |
Ezra Felker
NuPathe, Inc.
|
Brian Halak, Ph.D.
Domain Associates |
Karen Hong, Ph.D.
ProQuest Investments |
Paul Horan, Ph.D.
Prescriptive Kinetics |
Elaine V. Jones, Ph.D.
Euclid SR Partners
|
Hyman R. Kahn, M.D.
LORE
|
Frank Lexa, M.D.
University of Pennsylvania |
Sandra Matalonis
Iroko Pharmaceuticals, LLC |
Meryle J. Melnicoff, Ph.D.
The Wistar Institute |
Jennifer Miller
Ballard Spahr Andrews & Ingersoll, LLP
|
John Moran
Robin Hood Ventures |
Thomas Olenzak
Fountainhead Venture Group |
John Park
Cardinal Health Partners |
Michael Pellini, MBA, MD
Safeguard Scientifics, Inc. |
Gregory J. Rice, Esq.
High Road Consulting |
Matt Rieke, M.D.
Quaker BioVentures |
Carin (Mueller) Rollins
5AM Ventures |
David Twersky
Robin Hood Ventures
|
Tracy Warren
Battelle Ventures
|
|
| II. LIFE SCIENCES TECHNOLOGY ADVISORY COMMITTEE (TAC) |
H. William Bosch, Ph.D.
Elan Nanosystems |
David Counts, Ph.D.
Angle Technology |
George Dytko
|
Robert B. McGrath, Ph.D.
Drexel University |
Banu Onaral, Ph.D.
Drexel University |
Ruth Perry, M.D.
Rohm & Haas Company |
Todd Ranheim
Merck
|
Philip Sass, Ph.D.
Morphotek, Inc. |
Paul M. Simon, Ph.D.
|
Elliot Sloane, Ph.D.
Villanova University
|
Gretchen L. Temeles, Ph.D.
Fish & Richardson, P.C. |
Margaret Wheatley, Ph.D.
Drexel University |
Modified: 06/05/08 |
